Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Tcs Biosciences Limited investment portfolio
Tcs Biosciences Limited has made numerous investments in companies such as Cytomark, Marrabio, and Caltag Medsystems within the Healthcare & Life Sciences sector.
unknown
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Caltag Medsystems Limited Caltag Medsystems Ltd manufactures cell‑stabilisation reagents and related flow‑cytometry products, such as the TransFix® sample stabiliser and blood collection tubes, for use in hospitals, reference laboratories, academic research institutions, pharmaceutical and biotechnology companies, and government agencies. | Healthcare & Life Sciences | Buckingham | Confirmed | 2026-03-06 |
| Cytomark Limited Cytomark Limited develops and distributes TransFix, a cell‑stabilisation reagent that preserves cellular antigens for flow cytometry. The product is sold to hospitals, reference laboratories, academic research institutions, pharmaceutical and biotechnology companies, and government agencies. | Healthcare & Life Sciences | Buckingham | Confirmed | 2026-03-05 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
3 more similar investors hiddenSign up to unlock →
Shareholding changes (3)
Tcs Biosciences Limited's positions across portfolio companies2026
- A ORDINARY 98,039 → 294,117
- ORDINARY 0 → 9,198